Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer.
01/01/2020
/
Publications
/
Model-based approach
Quality of life
Published in the British Journal of Radiology by the Groningen group, this review paper examined the outcome reports of oropharyngeal cancer patients treated...
Neurocognitive function and quality of life after proton beam therapy for brain tumour patients.
01/01/2020
/
Publications
/
Quality of life
Published in the Green Journal, this multicenter study reported 62 brain tumor adult patients neurocognitive function after PBT. For two years of followup time...
Long-term Health Related Quality of Life in Pediatric Brain Tumor Survivors Treated with Proton Radiotherapy at <4 Years of Age.
01/09/2020
/
Publications
/
Quality of life
Fifty-nine brain tumor children < 4 years old received PRT were followed for the median 9.1 years (5.5-18 years). The report of long-term health related quality...
Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy.
07/07/2019
/
Publications
/
Quality of life
The dosimetric advantages of PBT over photon radiotherapy may be clear but the translation of this benefit into clinically meaningful reductions in toxicities...
A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiotherapy for Esophageal Cancer.
07/07/2019
/
Publications
/
Quality of life
This study by Mayo Clinic aimed to compare Functional Assessment of Cancer Therapy - Esophagus (FACT-E) questionnaire changes during proton (PRT) or photon (XRT...
Improved LT patient-reported health and well-being outcomes of early-stage breast cancer treated with partial breast PT.
11/11/2018
/
Publications
/
Quality of life
This cross sectional survey study by Loma Linda University compared patient-reported QoL outcomes among women with stage 0-2 disease treated with lumpectomy...
Initial toxicity, QoL outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated vs. standard fractionated PT for low-risk prostate cancer
08/02/2018
/
Publications
/
Hypofractionation
Quality of life
A multi-center prospective phase 3 randomized trial aimed to identify differences in toxicity and quality-of-life outcomes between standard fractionation and...
Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.
08/09/2018
/
Publications
/
Quality of life
A study by the Seattle group analyzed 231 patients of localized prostate cancer treated with protons. Median follow-up was 1.7 years. Grade 3 toxicity was seen...
Current status of proton therapy outcome for paediatric cancers of the central nervous system - Analysis of the published literature.
08/10/2018
/
Publications
/
Quality of life
In childhood cancer survivors, over 60% report one or more radiation-related late toxicities while half of these adverse events are graded as life-threatening...
Finding Value for Protons: The Case of Prostate Cancer?
05/04/2018
/
Publications
/
Dosimetry
Quality of life
A review by UPenn examined the dosimetric data and clinical outcome reports. Clinical studies largely suggest no difference in urinary side effects or erectile...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.